Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9284442 | Revue de Pneumologie Clinique | 2005 | 7 Pages |
Abstract
Drugs are frequently incriminated as the cause of interstitial pneumonia. There are two major mechanisms of drug-associated interstitial lung disease: direct toxicity and immunoallergic reaction. When a drug is suspected, the difficulty lies in obtaining proof. The chronology of the disease and its manifestations together with earlier evidence reported in the literature can lead to a tentative diagnosis of drug-associated interstitial pneumonia. Proof is obtained through surveillance during the disease course. In nearly all patients, therapeutic decisions must be taken on the basis of suspected drug involvement.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
Charles Mayaud, Muriel Fartoukh, Antoine Parrot, Jacques Cadranel, Bernard Milleron, Georges Akoun,